Related Experiment Video
Updated: Jun 11, 2026

Surgical Procedures for a Rat Model of Partial Orthotopic Liver Transplantation with Hepatic Arterial Reconstruction
Published on: March 7, 2013
ADAMTS13 activity decreases after hepatectomy, reflecting a postoperative liver dysfunction
Eiji Okano1, Saiho Ko, Hiromichi Kanehiro
1Department of Surgery, Nara Medical University, Kashihara, Nara, Japan. eokano@naramed-u.ac.jp
ADAMTS13 activity significantly decreases after liver surgery, indicating potential liver dysfunction. Monitoring this enzyme may help prevent liver failure following hepatectomy.
Area of Science:
- Hepatology
- Vascular Biology
- Coagulation Science
Background:
- Hepatic function deterioration post-liver surgery mechanisms remain unclear.
- ADAMTS13 cleaves von Willebrand factor multimers; reduced activity may cause platelet aggregation and liver dysfunction.
- Microcirculatory disturbances following hepatectomy can exacerbate liver dysfunction.
Purpose of the Study:
- To evaluate changes in plasma ADAMTS13 activity after hepatectomy.
- To determine the clinical relevance of ADAMTS13 activity in patients undergoing liver surgery.
Main Methods:
- Sequential measurement of plasma ADAMTS13 activity in 70 patients post-hepatectomy.
- Analysis of correlations between ADAMTS13 activity and surgical factors or clinical outcomes.
Main Results:
- ADAMTS13 activity significantly decreased post-hepatectomy (67.0% to 48.1%).
- Prolonged Pringle's maneuver and major hepatectomy were associated with decreased ADAMTS13 activity.
- Reduced ADAMTS13 activity correlated with postoperative thrombocytopenia and hyperbilirubinemia.
Conclusions:
- ADAMTS13 activity reduction post-hepatectomy is linked to ischemic injury and liver mass reduction.
- Decreased ADAMTS13 activity reflects postoperative liver dysfunction.
- Monitoring ADAMTS13 activity could aid in preventing liver failure after hepatectomy.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
